HMGB1 and Traumatic Brain Injury
HMGB1 and Traumatic Brain Injury
批准号:
8316213
负责人:
KRISHNAN M. DHANDAPANI
金额:
$31.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31
关键词:
AcuteAcute Brain InjuriesAddressAmericanAstrocytesBiological MarkersBrainBrain EdemaCause of DeathCerebral EdemaCerebral IschemiaCerebrospinal FluidClinicalClinical ManagementComaCraniocerebral TraumaDataDevelopmentEconomic BurdenEdemaEtiologyEventExtracellular SpaceFutureGeneticGlutamate ReceptorGlutamatesGoalsHMGB ProteinsHMGB1 ProteinHumanIncidenceIndividualInflammationInflammatoryInterleukin-1 ReceptorsIntracranial HypertensionKnockout MiceLaboratoriesLesionLigandsLiquid substanceMeasurementMeasuresMediatingMedicalMembrane ProteinsMilitary PersonnelMolecularMusMutant Strains MiceN-Methyl-D-Aspartate ReceptorsNMDA receptor A1Natural ImmunityNecrosisNervous System TraumaNeurological outcomeNeuronal InjuryNeuronsOutcomePathway interactionsPatientsProcessRodentRoleScanningSecondary toSensorimotor functionsSerumSignal TransductionSocietiesSwellingTherapeuticTimeToll-like receptorsTraumatic Brain InjuryWorkX-Ray Computed Tomographyaquaporin 4basecell typecellular developmentclinically relevantdisabilityexcitotoxicityextracellularimprovedinhibitor/antagonistinsightmortalityneuroinflammationnew therapeutic targetnovelnovel therapeuticsoutcome forecastreceptortoll-like receptor 4transcription factorwater channelyoung adult
中文摘要
项目摘要
创伤性脑损伤是一种破坏性的神经损伤,其病死率超过1%。
每年有数百万人,包括大量的年轻人和军人
人事部。脑水肿与颅内压升高有关
(颅内压)和较差的临床结果,尽管细胞
这一过程背后的机制仍不清楚。这一差距在
对脑水肿形成的了解有助于临床上缺乏...
对脑外伤患者有效的治疗方法。我们实验室最近的工作
表明急性神经元坏死刺激了高密度脂蛋白的被动释放
迁移率组盒蛋白1(HMGB1),进而诱导胶质细胞肿胀和
脑水肿。具体目标1将确定个人是否被激活
NMDA受体亚基增加神经元损伤和脑水肿
实验性脑外伤。NR2A和NR2B基因敲除小鼠的加入将
确定单个NR2亚基是否对HMGB1的释放有贡献
头部创伤后的肿胀和神经学结果。特定目标
2将确定Toll样受体-4(TLR4)是否介导
HMGB1促进炎症和脑水肿的作用。的能力
HMGB1刺激星形细胞水通道,AQP4,也将被解决
在TLR4突变小鼠中。具体目标3将确定HMGB1是否可以
代表一种新的预测脑水肿发展的生物标志物
人类的头部创伤。体内HMGB1水平的测量
神经创伤患者脑脊液与血清的相关性研究
有急性神经元损伤和神经学后果。总而言之,建议的
研究将调查HMGB1-TLR4信号的新可能性
导致脑水肿和术后颅内压升高
TBI。这些研究的结果可能会为小说的未来发展提供支持
针对这一途径的治疗方法以限制以下神经损伤
头部创伤。
英文摘要
Project Summary
Traumatic brain injury (TBI) is a devastating neurological injury afflicting over 1
million people annually, including a large number of young adults and military
personnel. Cerebral edema is associated with increased intracranial pressure
(ICP) and a poor clinical outcome following TBI, although the cellular
mechanisms underlying this process remain unknown. This gap in the
understanding of cerebral edema formation contributes to the lack of clinically-
effective therapeutics for TBI patients. Recent work by our laboratory
demonstrates that acute neuronal necrosis stimulates the passive release of high
mobility group box protein 1 (HMGB1), which in turn induces glial swelling and
cerebral edema. Specific Aim 1 will establish whether activation of individual
NMDA receptor subunits increase neuronal injury and cerebral edema following
experimental TBI. The incorporation of NR2A and NR2B knockout mice will
determine whether individual NR2 subunits contribute to HMGB1 release, brain
swelling, and neurological outcome using following head trauma. Specific Aim
2 will determine whether toll-like receptor-4 (TLR4) mediates the pro-
inflammatory and cerebral edema promoting effects of HMGB1. The ability of
HMGB1 to stimulate the astrocytic water channel, AQP4, will also be addressed
in TLR4 mutant mice. Specific Aim 3 will determine whether HMGB1 may
represent a novel biomarker to predict the development of cerebral edema
folowing head trauma in humans. Measurement of HMGB1 levels within the
cerebrospinal fluid (CSF) and serum of neurotrauma patients will be correlated
with acute neuronal injury and neurological outcome. Together, the proposed
studies will investigate the novel possibility that HMGB1-TLR4 signaling
contributes to the development of cerebral edema and increased ICP following
TBI. The results of these studies may support the future development of novel
therapeutics directed against this pathway to limit neurological injury following
head trauma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunometabolic regulation after CNS injury
-
批准号:10737334
-
项目类别:
-
资助金额:$197.53万
-
财政年份:2023
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Augusta SPAN 2
-
批准号:10591250
-
项目类别:
-
资助金额:$61.6万
-
财政年份:2023
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Remote ischemic Conditioning Promotes Cerebrovascular Recovery after Intracerebral Hemorrhage
-
批准号:10240740
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2020
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Remote ischemic Conditioning Promotes Cerebrovascular Recovery after Intracerebral Hemorrhage
-
批准号:10676330
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2020
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Remote ischemic Conditioning Promotes Cerebrovascular Recovery after Intracerebral Hemorrhage
-
批准号:10459588
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2020
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Remote ischemic Conditioning Promotes Cerebrovascular Recovery after Intracerebral Hemorrhage
-
批准号:10035049
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2020
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
NLRP3 inflammasome and TBI
-
批准号:8570673
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2013
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
NLRP3 inflammasome and TBI
-
批准号:8666092
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2013
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Therapeutic targeting of CD36 after intracerebral hemorrhage
-
批准号:8432013
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2012
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
Therapeutic targeting of CD36 after intracerebral hemorrhage
-
批准号:8303510
-
项目类别:
-
资助金额:$18.71万
-
财政年份:2012
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
HMGB1 and Traumatic Brain Injury
-
批准号:8525465
-
项目类别:
-
资助金额:$30.41万
-
财政年份:2009
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
HMGB1 and Traumatic Brain Injury
-
批准号:7792899
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2009
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位:
HMGB1 and Traumatic Brain Injury
-
批准号:8119453
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2009
-
负责人:KRISHNAN M. DHANDAPANI
-
依托单位: